Daily Market Recap: October 30, 2025

On October 30, 2025, U.S. small-cap equities exhibited extraordinary volatility, with biotechnology and technology–related issuers leading the advance. A clutch of micro-cap names more than doubled on heavy trading volume, reflecting a broad appetite for speculative and news-driven stocks. Below is a snapshot of key movers, followed by analysis of overarching trends and stand-out performances.

Market Snapshot

Ticker	ATTN Price	Current Price	Volume	Price Change %
INTS	0.3439	0.9352	838,202,400	171.88%
VCIG	0.9976	1.9300	25,266,882	93.46%
CMBM	1.4683	3.2200	141,043,112	119.35%
MBRX	0.3742	0.4647	19,785,818	24.22%
JZXN	0.2816	0.3560	28,489,468	26.40%
FMC	10.7765	15.4100	27,003,019	42.95%
WOLF	23.1400	26.1500	3,492,434	13.01%
CERO	0.0184	0.0900	20,788,751	388.51%
TECX	11.6071	17.6407	2,373,109	51.96%
VIVS	2.0366	2.7500	10,812,886	35.02%
HBIO	0.3828	0.6873	182,399,272	79.56%
ADTX	0.0549	0.0697	20,773,154	26.83%
GLE	0.5113	0.7630	28,743,098	49.29%
VIVK	0.1381	0.2470	89,021,936	78.85%
FMFC	0.9542	1.6400	716,303	71.90%
MSAI	0.8962	1.3200	67,133,663	47.32%
MSPR	0.1205	0.2900	3,115,138	140.71%
EBS	10.3335	12.7799	5,130,176	23.71%
ARBB	5.6722	6.8600	1,049,277	20.89%
WETH	1.2900	2.5800	1,642,789	100.00%

Market Analysis

Biotechnology and life-science micro-caps dominated today’s leaderboard, buoyed by fresh financing announcements, clinical trial updates and strategic partnerships. CERO Therapeutics (CERO) led all gainers, rocketing 388.5% on the back of governance updates and investor interest in its CER-T trial. Intensity Therapeutics (INTS) climbed 171.9% after disclosing an $11 million capital raise to advance two Phase 3 cancer trials.

Technology-focused names also registered outsized moves. Cambium Networks (CMBM) surged 119.4%, propelled by word of a Starlink integration deal and a Wi-Fi 7 product rollout. VCIG nearly doubled after reporting encouraging early data for its digital health platform. WETOUCH Technology (WETH) closed up 100% following confirmation of a factory-expansion funding round.

Volume patterns underscore the speculative nature of today’s rally. Intensity Therapeutics led volume with more than 838 million shares changing hands, while HBIO saw 182 million shares traded. Multiple tickers crossed 100 million in volume, demonstrating robust intraday liquidity in the beaten-down small-cap arena.

Not all names moved in lockstep with the leaders. FMC Corporation (FMC) advanced 42.9% on contract wins in its crop-protection segment, but traded at a fraction of the astronomical volumes seen in biotech plays. More established small-caps such as WOLF and EBS registered moderate gains on comparatively lighter flows.

Small-cap stocks by rc.xyz NFT gallery

Significant Movers and Volume Surges

• CERO’s 388.5% jump stands out as the day’s most dramatic move, lifting its market price from $0.0184 to $0.09.
• Intensity Therapeutics (INTS) and MSP Recovery (MSPR) both doubled or more, reflecting fundraising milestones and investor optimism.
• Volume spikes in INTS, HBIO and CMBM highlight a broader risk-on posture among small-cap traders.
• Technological catalysts drove TECX (+52.0%) and GLE (+49.3%), reinforcing the appetite for network-equipment and data-analytics stories.

TL;DR

• Small-cap biotech and tech stocks rallied sharply on trial updates, financing news and strategic partnerships.
• CERO Therapeutics soared 388.5% on governance and trial progress; INTS surged 171.9% after an $11 million raise.
• High-volume leaders included INTS (838 M), HBIO (182 M) and CMBM (141 M).
• Broader market sentiment favored speculative micro-caps, with several names doubling in a single session.